Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Portfolio Pulse from Lisa Levin
The article lists the stocks that gained and lost in Tuesday's mid-day session. Notable gainers include SciSparc Ltd., Cardio Diagnostics Holdings, Inc., and Verve Therapeutics, Inc. due to positive news such as patent acceptance and contract acquisition. On the other hand, Kintara Therapeutics, Inc., Galera Therapeutics, Inc., and reAlpha Tech Corp. were among the biggest losers due to negative developments like unsuccessful drug trials and poor financial results.
October 31, 2023 | 5:36 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cardio Diagnostics Holdings, Inc. gained 53.1% after the company received an Innovation Technology contract from Vizient for its novel AI-driven precision heart disease tests.
The acquisition of the Innovation Technology contract from Vizient for its AI-driven precision heart disease tests is a positive development for Cardio Diagnostics Holdings, Inc., which could lead to increased investor confidence and a potential rise in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
SciSparc Ltd. shares climbed 80% after the company announced it received notice of acceptance from the Australian patent office for its patent application.
The acceptance of the patent application by the Australian patent office is a positive development for SciSparc Ltd., which could lead to increased investor confidence and a potential rise in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Kintara Therapeutics, Inc. shares dipped 76.7% after the company announced that its drug VAL-083 did not outperform existing treatments for glioblastoma, a severe brain cancer.
The announcement that Kintara Therapeutics, Inc.'s drug VAL-083 did not outperform existing treatments for glioblastoma is a negative development for the company, which could lead to decreased investor confidence and a potential drop in the stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100